SEC Form 4 · accession 0001144204-17-018188
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Uri A Lopatin
Officer — Chief Med. Off., VP Res. Dev.
Period of report
Mar 29, 2017
Accepted (ET)
Mar 31, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $25.34 | Mar 29, 2017 | A | 12,500 | A | — | Mar 29, 2027 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The options vest over two years as follows: 50% shall vest on the first anniversary of the date of grant, March 29, 2018; and the remaining 50% shall vest in 12 equal monthly installments, with the options becoming fully vested on March 29, 2019.